🇺🇸 FDA
Patent

US 6875433

Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotein

expired A61KA61K2039/505

Quick answer

US patent 6875433 (Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotein) held by The United States of America as represented by the Secretary of the Army expires Mon Mar 31 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Apr 05 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 31 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/505